Clinical and psychopathological characteristics of patients with late-onset schizophrenia and schizophrenia-like psychoses in clusters identified by biological parameters
- 23 April 2024
- journal article
- abstracts
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (4) , 137-144
Abstract
OBJECTIVE To assess clinical and psychopathological characteristics of late-aged female patients with late-onset psychoses in clusters formed on the basis of biochemical and immunological blood parameters. MATERIAL AND METHODS We examined 59 women with schizophrenia and schizophrenia-like psychoses with onset after 40 years (ICD-10 F20, F22.8, F25, F23, F06.2), including 34 women with late-onset (40—60 years) and 25 with very late onset psychoses (after 60 years). At the time of hospitalization, a clinical/ psychopathological study was carried out using CGI-S, PANSS, CDSS, and HAMD-17, as well as the activities of glutathione reductase (GR) and glutathione-S-transferase (GT) have been determined in erythrocyte hemolysates, and the activities of leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) have been assessed in blood plasma. Biochemical and immunological parameters have been also determined in 34 age-matched mentally healthy women. RESULTS Clustering by signs such as GR, GT, LE and α1-PI has yielded two clusters of objects (patients) significantly different in GT (pppp=0.04) and higher total scores on PANSS subscales’ items. Cluster 1 includes 76% of patients with very late onset. Different correlations between clinical and biological signs are found in two clusters. CONCLUSION The identified clusters have different clinical and psychopathological characteristics. Dividing patients into subgroups according to biochemical and immunological parameters is promising for the search for differentiated therapeutic approaches.Keywords
This publication has 26 references indexed in Scilit:
- Redox and Immune Signaling in Schizophrenia: New Therapeutic PotentialInternational Journal of Neuropsychopharmacology, 2023
- Potential Roles of Redox Dysregulation in the Development of SchizophreniaBiological Psychiatry, 2020
- Reactive oxygen species (ROS) as pleiotropic physiological signalling agentsNature Reviews Molecular Cell Biology, 2020
- The Neuropsychological Profile and Phenomenology of Late Onset Psychosis: A Cross-sectional Study on the Differential Diagnosis of Very-Late-Onset Schizophrenia-Like Psychosis, Dementia with Lewy Bodies and Alzheimer’s Type Dementia with PsychosisArchives of Clinical Neuropsychology, 2018
- Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-AnalysisInternational Journal of Neuropsychopharmacology, 2017
- Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset SchizophreniaJournal of Child and Adolescent Psychopharmacology, 2016
- The role of glutathione reductase and related enzymes on cellular redox homoeostasis networkFree Radical Biology and Medicine, 2016
- Elevated C-Reactive Protein Associated With Late- and Very-Late-Onset Schizophrenia in the General Population: A Prospective StudySchizophrenia Bulletin, 2013
- Aging and Neutrophils: There Is Still Much To DoRejuvenation Research, 2008
- Ageing and the neutrophil: no appetite for killing?Immunology, 2000